Our results most closely match those from the Alzheimer’s Disease Neuroimaging Initiative, Australian Imaging, Biomarker and Lifestyle Study, and Harvard Aging Brain Study, which showed that APOE ε4 itself is not a major factor in clinical progression18. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.